Laserfiche WebLink
DocuSign Envelope ID:040056EC-0D41-4D98-9C65-E01AE876A6AB <br /> 4. Provide resources to staff government oversight and management of opioid <br /> abatement programs. <br /> 5. Support multidisciplinary collaborative approaches consisting of, but not limited <br /> to, public health, public safety, behavioral health, harm reduction, and others at <br /> the state, regional, local, nonprofit, and community level to maximize collective <br /> impact. <br /> K. TRAINING <br /> In addition to the training referred to throughout this document, support training to abate <br /> the opioid epidemic through activities, programs, or strategies that may include, but are <br /> not limited to,those that: <br /> 1. Provide funding for staff training or networking programs and services to improve <br /> the capability of government, community, and not-for-profit entities to abate the <br /> opioid crisis. <br /> 2. Support infrastructure and staffing for collaborative cross-system coordination to <br /> prevent opioid misuse, prevent overdoses, and treat those with OUD and any co- <br /> occurring SUD/MH conditions, or implement other strategies to abate the opioid <br /> epidemic described in this opioid abatement strategy list(e.g., health care, <br /> primary care, pharmacies, PDMPs, etc.). <br /> L. RESEARCH <br /> Support opioid abatement research that may include,but is not limited to,the following: <br /> 1. Monitoring, surveillance, data collection and evaluation of programs and <br /> strategies described in this opioid abatement strategy list. <br /> 2. Research non-opioid treatment of chronic pain. <br /> 3. Research on improved service delivery for modalities such as SBIRT that <br /> demonstrate promising but mixed results in populations vulnerable to <br /> opioid use disorders. <br /> 4. Research on novel harm reduction and prevention efforts such as the <br /> provision of fentanyl test strips. <br /> 5. Research on innovative supply-side enforcement efforts such as improved <br /> detection of mail-based delivery of synthetic opioids. <br /> 6. Expanded research on swift/certain/fair models to reduce and deter opioid <br /> misuse within criminal justice populations that build upon promising <br /> approaches used to address other substances (e.g., Hawaii HOPE and <br /> Dakota 24/7). <br /> 7. Epidemiological surveillance of OUD-related behaviors in critical <br /> populations, including individuals entering the criminal justice system, <br /> 12 <br />